Programme
09.30 Coffee & Registration
09.55 Session I Chair: Klaus Rumpel
10.00 Susanne Müller-Knapp Goethe Universität Frankfurt, Germany
The impact of Open Science Chemical Probes
10.40 Alessio Ciulli University of Dundee, UK
Targeted protein degradation with small molecules: How PROTACs work
11.20 Ed Tate Imperial College London, UK
Protein lipidation: From biological systems to drug discovery
12.00 Lunch & Posters
13.15 Session II Chair: Colin Bedford
13:20 Early Career Scientist, Talk 1
13:35 Early Career Scientist, Talk 2
13.50 Bernhard Küster Technische Universität München, Germany
Target landscape and signaling networks of kinase inhibitor drugs
14:30 Sila Ultanir The Francis Crick Institute, London, UK
Chemical genetic methods for kinase substrate identification
15.10 Coffee
15:30 Early Career Scientist, Talk 3
15:45 Julio Saez-Rodriguez RWTH Aachen, Germany
Network models to dissect the effect of genetic and chemical perturbations in cancer
16:25 Dimitrios Anastasiou The Francis Crick Institute, London, UK
Unravelling metabolic vulnerabilities of cancer cells by revisiting a drug's mode of action
17:10 Closing Remarks Klaus Rumpel
09.30 Coffee & Registration
09.55 Session I Chair: Klaus Rumpel
10.00 Susanne Müller-Knapp Goethe Universität Frankfurt, Germany
The impact of Open Science Chemical Probes
10.40 Alessio Ciulli University of Dundee, UK
Targeted protein degradation with small molecules: How PROTACs work
11.20 Ed Tate Imperial College London, UK
Protein lipidation: From biological systems to drug discovery
12.00 Lunch & Posters
13.15 Session II Chair: Colin Bedford
13:20 Early Career Scientist, Talk 1
13:35 Early Career Scientist, Talk 2
13.50 Bernhard Küster Technische Universität München, Germany
Target landscape and signaling networks of kinase inhibitor drugs
14:30 Sila Ultanir The Francis Crick Institute, London, UK
Chemical genetic methods for kinase substrate identification
15.10 Coffee
15:30 Early Career Scientist, Talk 3
15:45 Julio Saez-Rodriguez RWTH Aachen, Germany
Network models to dissect the effect of genetic and chemical perturbations in cancer
16:25 Dimitrios Anastasiou The Francis Crick Institute, London, UK
Unravelling metabolic vulnerabilities of cancer cells by revisiting a drug's mode of action
17:10 Closing Remarks Klaus Rumpel
